WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Farms a hive of activity across ChinaInstalled capacity of wind farms in Tianjin reaches 1.296 mln kwMacron, Le Pen lead 1st round of French presidential electionChina launches new landNation ranks 2nd for new unicorns in '233D printed storage box to further propel China's lunar missionAerial view of heartFollow Xi's Steps: Why Did President Xi Visit Suzhou Industrial Park?Boundary question should be placed appropriately in ChinaChina accelerates issuance of local
4.1332s , 6501.9453125 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,International Interactions news portal